Steve Burrill, Founder and CEO of investment firm Burrill & Company, will deliver his respected annual analysis of the life science industry: opportunities, challenges and trends for the next year. Steve’s firm has $1.5 billion in assets under management and includes venture capital/private equity, merchant banking, and media, operating in the US and globally. His view of the industry derives from the scientific and business networks of his team, participation on numerous Advisory Boards; the strategic and financial network of the firm’s limited partners; and the close relationships developed with numerous life science companies and management. Join us to learn what’s in store for the industry and where you should focus to take advantage of the opportunities. Reception sponsored by Goodwin Procter. Tickets.